Detalhe da pesquisa
1.
In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB(1) receptor antagonist for the management of obesity.
Biochem Biophys Res Commun
; 394(2): 366-71, 2010 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211605